Notice: Passwords are now case-sensitive

Remember Me
Register a new account
Forgot your password?



Community Requests

BWC Formulary Proposal Is Big News for Opioid Maker

Tuesday, November 28, 2017 | 491 | 0 | 4 min read

A company that makes two opioid drugs that are administered by applying a patch to the inside of the cheek is touting the potential addition of its products to Ohio’s workers’ compensation drug formulary. BioDelivery Sciences International Inc. makes Belbuca, an inside-the-cheek buprenorphine film, and Bunavail, a buprenorphine-and-naloxone film. The Ohio Bureau of Workers’ Compensation has proposed adding Belbuca to the formulary as a long-acting opioid, without restrictions. Bunavail would be added to the formulary and covered in claims with an allowed condition for opioi...

Purchase this story for only $7.99!Add to Cart

For access to all of our articles, check out our subscription options.


Be the first to comment.

Related Articles